Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.
about
Acute effect of protein or carbohydrate breakfasts on human cerebrospinal fluid monoamine precursor and metabolite levelsLabelled alpha-methyl-L-tryptophan as a tracer for the study of the brain serotonergic systemEffect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal fluidPrecursors and metabolites of phenylethylamine, m and p-tyramine and tryptamine in human lumbar and cisternal cerebrospinal fluidCSF concentration gradients of monoamine metabolites in patients with hydrocephalus.Study of the brain serotonergic system with labeled alpha-methyl-L-tryptophan.Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental studyDifferences between males and females in rates of serotonin synthesis in human brain.Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the ventricular cerebrospinal fluid of patients with obstructive hydrocephalusTryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs.Spinal reflexes and the concentrations of 5-HIAA, MHPG, and HVA in lumbar cereborspinal fluid after spinal lesions in man.Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.Effect of concomitant administration of three different antidepressants with vitamin B6 on depression and obsessive compulsive disorder in mice modelsThe biochemistry of the basal ganglia and Parkinson's disease.Monoamine neurotransmitter disorders--clinical advances and future perspectives.Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.Transmitter precursors and metabolites in human ventricular cerebrospinal fluid.Relationship between rat brain and cisternal CSF tryptophan concentrations.Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine.The circadian variation in dopamine metabolism in the subhuman primate.Histamine metabolites in cerebrospinal fluid of the rhesus monkey (Macaca mulatta): cisternal-lumbar concentration gradients.On the elimination of centrally formed 5-hydroxyindoleacetic acid by cerebrospinal fluid and urine.Neuropharmacology of progressive myoclonus epilepsy: response to 5-hydroxy-L-tryptophan.Homovanillic acid and 3-methoxy-4-hydroxyphenylethyleneglycol production by the monkey spinal cord.Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects.Selective decrease in central nervous system serotonin turnover in children with dopa-nonresponsive dystonia.Theodore L. Sourkes PhD, FRSC, OC (February 21, 1919-January 17, 2015).Changes in the tryptophan content of excised human cerebral cortex.Monitoring the effect of a tryptophan load on brain indole metabolism in freely moving rats by simultaneous cerebrospinal fluid sampling and brain dialysis.Effects of phosphatidylserine therapy in geriatric patients with depressive disorders.
P2860
Q28339394-9CB766E2-7E17-423E-916B-DE3C0A488FC5Q28361167-706ABD63-359A-4534-B3F8-BD20F97B5DE5Q28365845-74A13D2D-42EB-416C-AA0E-74522CC4F5D2Q28365875-37C8E73B-5A62-4256-908C-E956055847EEQ33733043-0A8BE2A7-C9E3-4EF9-93E7-1FF876774DF7Q34386607-92DDE9DA-5858-438A-9588-BE22D78AACE4Q34408564-57EE43F5-B4AC-4AE0-942A-2E4C2CFC9F65Q36772213-39D26961-EFCE-4D3A-A6E5-C70A20FA3B7FQ36991504-EC4B9824-A3E0-4DFF-BB37-81F423802D0FQ36998909-E234CA70-3DEA-481F-A163-CACA377C6D0EQ37048697-1EB72CAF-3850-4B12-A411-B83C899938C3Q37054783-F7A875F2-34DA-41FD-BA5B-1763AF81118AQ37676884-C9F37D41-02AA-456C-A0FF-CA06AC0E6EFBQ38161004-7BE643FD-5B57-454B-B447-9CAC1CFAA3E3Q38590771-963F0905-D018-4F7C-8171-786AEE51C222Q38937893-8B048755-08C0-4C76-80DA-14F4EFC5C0E1Q39090090-6D51088E-6E1D-477F-A082-3F2ACB913D32Q39300849-CA19DB35-9452-4DEA-9EBE-4BF4F48EFD51Q40747144-55E257EB-5F6B-474A-A6A7-2C0E600DB812Q41272436-5BF87E2D-1F0D-4319-ACB9-911C8ACE407AQ41422039-01A551C5-BBB0-46DD-B0B8-BC1657A1FA8CQ41504693-396C067E-22F6-4C23-A606-DA8757CD23A1Q41666470-42BBFCC5-869D-41C6-A60B-2B7F85908BF4Q41961478-B11FB2FF-241C-4FA6-8544-26AB72284FFBQ42243704-2D0285B2-05D8-4329-98B4-9E62543D81E7Q44042009-A73F403A-6187-499F-8001-A00433C9315FQ47811311-5809CB1A-8485-46E6-BF2F-1ED016721408Q48316033-6D327A05-8AEB-458E-A347-08A435B178CCQ48505886-A14D780F-C2DD-4AC8-907F-E450B3B9CEA5Q49092488-A9351A34-0661-4B27-BFE8-08614345F8AA
P2860
Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.
description
1974 nî lūn-bûn
@nan
1974年の論文
@ja
1974年学术文章
@wuu
1974年学术文章
@zh-cn
1974年学术文章
@zh-hans
1974年学术文章
@zh-my
1974年学术文章
@zh-sg
1974年學術文章
@yue
1974年學術文章
@zh
1974年學術文章
@zh-hant
name
Monoamine metabolites in lumba ...... relation to clinical studies.
@en
Monoamine metabolites in lumba ...... relation to clinical studies.
@nl
type
label
Monoamine metabolites in lumba ...... relation to clinical studies.
@en
Monoamine metabolites in lumba ...... relation to clinical studies.
@nl
prefLabel
Monoamine metabolites in lumba ...... relation to clinical studies.
@en
Monoamine metabolites in lumba ...... relation to clinical studies.
@nl
P2093
P1433
P1476
Monoamine metabolites in lumba ...... relation to clinical studies.
@en
P2093
P356
10.1016/0006-8993(74)90562-9
P577
1974-10-01T00:00:00Z